AU2001273801A1 - Dehydrobaimuxinol derivatives use as medicaments for treating or preventing regressive diseases of brain - Google Patents

Dehydrobaimuxinol derivatives use as medicaments for treating or preventing regressive diseases of brain

Info

Publication number
AU2001273801A1
AU2001273801A1 AU2001273801A AU7380101A AU2001273801A1 AU 2001273801 A1 AU2001273801 A1 AU 2001273801A1 AU 2001273801 A AU2001273801 A AU 2001273801A AU 7380101 A AU7380101 A AU 7380101A AU 2001273801 A1 AU2001273801 A1 AU 2001273801A1
Authority
AU
Australia
Prior art keywords
dehydrobaimuxinol
medicaments
brain
treating
preventing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001273801A
Inventor
Hongju Fang
Ji-yu GUO
Chun Li
Ruiwu Liu
Weijun Wang
Dali Yin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Materia Medica of CAMS
Original Assignee
Institute of Materia Medica of CAMS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Materia Medica of CAMS filed Critical Institute of Materia Medica of CAMS
Publication of AU2001273801A1 publication Critical patent/AU2001273801A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001273801A 2000-05-12 2001-05-11 Dehydrobaimuxinol derivatives use as medicaments for treating or preventing regressive diseases of brain Abandoned AU2001273801A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN00108338 2000-05-12
CN00108338A CN1322525A (en) 2000-05-12 2000-05-12 Dehydrogenated falcate micromelum costusic alcohol derivative as medicine for preventing or treating cerebral retrogressive lesion
PCT/CN2001/000737 WO2002020505A1 (en) 2000-05-12 2001-05-11 Dehydrobaimuxinol derivatives use as medicaments for treating or preventing regressive diseases of brain

Publications (1)

Publication Number Publication Date
AU2001273801A1 true AU2001273801A1 (en) 2002-03-22

Family

ID=4579163

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001273801A Abandoned AU2001273801A1 (en) 2000-05-12 2001-05-11 Dehydrobaimuxinol derivatives use as medicaments for treating or preventing regressive diseases of brain

Country Status (3)

Country Link
CN (1) CN1322525A (en)
AU (1) AU2001273801A1 (en)
WO (1) WO2002020505A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106083771A (en) * 2016-06-13 2016-11-09 崔坤峰 The pharmaceutical composition of carbidopa and the medical usage for the treatment of liver cancer thereof
CN108947949B (en) * 2017-05-19 2022-08-19 泰州华元医药科技有限公司 Anxiolytic deuterated compounds and medical application thereof
CN108929299A (en) 2017-05-23 2018-12-04 北京元气知药科技有限公司 Buagafuran bulk pharmaceutical chemicals and its preparation method and application
CN114560833B (en) * 2021-03-23 2022-10-18 北京承颐医药科技有限公司 Agilawood furan compound and preparation method and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH608187A5 (en) * 1976-03-03 1978-12-29 Firmenich & Cie Perfuming composition
CN1199960C (en) * 1998-11-19 2005-05-04 中国医学科学院药物研究所 Agarofuran derivatives, their preparing process, medicinal composition containing them and their medicinal usage

Also Published As

Publication number Publication date
WO2002020505A1 (en) 2002-03-14
CN1322525A (en) 2001-11-21

Similar Documents

Publication Publication Date Title
AU2001247615A1 (en) Intracorporeal medicaments for photodynamic treatment of disease
AU2002332430A1 (en) Methods of treating neuropilin-mediated diseases
AU3009801A (en) Combinations of medicaments for treating viral diseases
AU2002252227A1 (en) Heterocyclic derivatives for the treatment of cancer and other proliferative diseases
AU2002226690A1 (en) Drugs for the diagnosis of tissue-reproductive activity or the treatment of proliferative diseases
AU2002210385A1 (en) Furazanyl-triazole derivates for the treatment of diseases
AU2002240359A1 (en) Pharmaceutical composition for the treatment of alopecia
AU2000258352A1 (en) Acupuncture points stimulation for treating various diseases
HUP0002963A3 (en) Use of pyrazolo-[4,3-d] pyrimidinon derivatives for the production of pharmaceutical compositions for treating diseases of the eye field
AU2000265525A1 (en) Medicament for treating intestinal diseases
AU2001232787A1 (en) Airway alkalinization as therapy for airway diseases
HUP0104963A3 (en) Compositions for the treatment of skin diseases
AU2002227895A1 (en) Sulphonamides for the treatment of central nervous system diseases
HK1057332A1 (en) Use of 3-benzoylphenylacetic acid derivatives for the treatment of retinal disorders
AU2001273801A1 (en) Dehydrobaimuxinol derivatives use as medicaments for treating or preventing regressive diseases of brain
AU3004000A (en) Methods for the treatment of apolipoprotein e related diseases
AU2002337862A1 (en) Methods of treating skin with diphosphonate derivatives
AU2002246151A1 (en) Azolylcarbynol derivatives of aryl (or heteroaryl) for the treatment of respiratory diseases
AU6076000A (en) Cyclic amine derivatives for the treatment of neurological diseases
AU2900100A (en) Methods for inhibiting cathepsin k activity for the treatment of diseases related to bone loss
AU3501100A (en) Synergistic combination for treatment of viral-mediated diseases
AU1405001A (en) Treatment of diseases
AU1022501A (en) Use of compositions for the caring treatment of the skin
AU2001264375A1 (en) Novel photosensitizers of 9-hydroxypheophorbide-a derivatives used for photocynamic therapy
HUP0301971A3 (en) Uses of thaliporphine or its derivatives for producing pharmaceutical compositions suitable for treating cardiac diseases and the compounds